Your browser doesn't support javascript.
loading
How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study.
Cherrez-Ojeda, Ivan; Vanegas, Emanuel; Cherrez, Annia; Felix, Miguel; Weller, Karsten; Magerl, Markus; Maurer, Rasmus Robin; Mata, Valeria L; Kasperska-Zajac, Alicja; Sikora, Agnieszka; Fomina, Daria; Kovalkova, Elena; Godse, Kiran; Rao, Nimmagadda Dheeraj; Khoshkhui, Maryam; Rastgoo, Sahar; Criado, Roberta Fj; Abuzakouk, Mohamed; Grandon, Deepa; Van Doorn, Martijn B A; Oliveira Rodrigues Valle, Solange; De Souza Lima, Eduardo Magalhães; Thomsen, Simon Francis; Ramón, German D; Matos Benavides, Edgar E; Bauer, Andrea; Giménez-Arnau, Ana M; Kocatürk, Emek; Guillet, Carole; Larco, Jose Ignacio; Zhao, Zuo-Tao; Makris, Michael; Ritchie, Carla; Xepapadaki, Paraskevi; Ensina, Luis Felipe; Cherrez, Sofia; Maurer, Marcus.
Afiliación
  • Cherrez-Ojeda I; Universidad Espíritu Santo, Samborondón, Ecuador.
  • Vanegas E; Respiralab, Respiralab Research Group, Guayaquil, Ecuador.
  • Cherrez A; Universidad Espíritu Santo, Samborondón, Ecuador.
  • Felix M; Respiralab, Respiralab Research Group, Guayaquil, Ecuador.
  • Weller K; Respiralab, Respiralab Research Group, Guayaquil, Ecuador.
  • Magerl M; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany.
  • Maurer RR; Universidad Espíritu Santo, Samborondón, Ecuador.
  • Mata VL; Respiralab, Respiralab Research Group, Guayaquil, Ecuador.
  • Kasperska-Zajac A; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.
  • Sikora A; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.
  • Fomina D; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.
  • Kovalkova E; Universidad Espíritu Santo, Samborondón, Ecuador.
  • Godse K; Respiralab, Respiralab Research Group, Guayaquil, Ecuador.
  • Rao ND; European Center for Diagnosis and Treatment of Urticaria, Medical University of Silesia, Katowice, Poland.
  • Khoshkhui M; European Center for Diagnosis and Treatment of Urticaria, Medical University of Silesia, Katowice, Poland.
  • Rastgoo S; City Center of Allergy and Immunology, Clinical City Hospital #52, Moscow, Russia.
  • Criado RF; Department of Allergology and Clinical Immunology, I.M. Sechenov First Moscow State Medical University, Trubetskaya St., 8/2, Moscow, 119991, Russian Federation.
  • Abuzakouk M; City Center of Allergy and Immunology, Clinical City Hospital #52, Moscow, Russia.
  • Grandon D; Department of Dermatology, D Y, Patil University School of Medicine and Hospital, Mumbai, India.
  • Van Doorn MBA; Department of Dermatology, D Y, Patil University School of Medicine and Hospital, Mumbai, India.
  • Oliveira Rodrigues Valle S; Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • De Souza Lima EM; Department of Allergy and Immunology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Thomsen SF; Department of Allergy and Immunology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ramón GD; Department of Dermatology, Faculdade de Medicina do ABC, São Paulo, Brazil.
  • Matos Benavides EE; Allergy and Immunology Department, Cleveland Clinic Abu Dhabi, United Arab Emirates.
  • Bauer A; Allergy and Immunology Department, Cleveland Clinic Abu Dhabi, United Arab Emirates.
  • Giménez-Arnau AM; Department of Dermatology, Erasmus MC, Rotterdam, the Netherlands.
  • Kocatürk E; Department of Internal Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil.
  • Guillet C; Faculty of Science and Health of Juiz de Fora - SUPREMA, Minas Gerais, Brazil.
  • Larco JI; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Biomedical Sciences, Copenhagen, Denmark.
  • Zhao ZT; Instituto de Alergia e Inmunología del Sur, Bahía Blanca, Prov. De Buenos Aires, Argentina.
  • Makris M; Centro de Referencia de Alergia, Asma e Inmunología - Instituto Nacional del Niño, Lima, Perú.
  • Ritchie C; Department of Dermatology, University Allergy Center, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany.
  • Xepapadaki P; Department of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma, Barcelona, Spain.
  • Ensina LF; Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.
  • Cherrez S; Department of Dermatology, University Hospital Zurich, Switzerland.
  • Maurer M; Allergy Department, Clinica San Felipe, Lima, Peru.
World Allergy Organ J ; 14(6): 100542, 2021 Jun.
Article en En | MEDLINE | ID: mdl-34141048
ABSTRACT

BACKGROUND:

Patients with chronic urticaria (CU) are increasingly using information and communication technologies (ICTs) to manage their health. What CU patients expect from ICTs and which ICTs they prefer remains unknown. We assessed why CU patients use ICTs, which ones they prefer, and what drives their expectations and choices.

METHODS:

In this cross-sectional study, 1841 patients across 17 countries were recruited at UCAREs (Urticaria Centers of Reference and Excellence). Patients with CU who were >12 years old completed a 23-item questionnaire.

RESULTS:

Most patients were interested in receiving disease information (87.3%), asking physicians about CU (84.1%), and communicating with other patients through ICTs (65.6%). For receiving disease information, patients preferred one-to-one and one-to-many ICTs, especially web browsers. One-to-one ICTs were also the ICTs of choice for asking physicians about urticaria and for communicating with other patients, and e-mail and WhatsApp were the preferred ICTs, respectively. Many-to-many ICTs such as Facebook, Instagram, LinkedIn, and Twitter were least preferred for all 3 purposes. Living in rural areas and higher education were linked to higher odds of being interested in receiving disease information, asking physicians, and communicating with patients through ICTs.

CONCLUSIONS:

Most patients and especially patients with higher education who live in rural areas are interested in using ICTs for their healthcare, but prefer different ICTs for different purposes, ie, web browsers for obtaining information, e-mail for asking physicians, and WhatsApp for communicating with other patients. Our findings may help to improve ICTs for CU.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: World Allergy Organ J Año: 2021 Tipo del documento: Article País de afiliación: Ecuador

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: World Allergy Organ J Año: 2021 Tipo del documento: Article País de afiliación: Ecuador